Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
FDA Allows Geron to Start Phase I Trial of Human Embryonic Stem Cells;Neurotech Begins Phase I Testing of Neurologic Drug;Efficacy of Gene Therapy for Severe Combined Immunodeficiency Syndrome Confirmed;Leukemia a Side Effect in Four;Trials Sponsored by Companies More Likely to Succeed;Pfizer Halts Trials of Monoclonal Antibody for Chronic Pain